Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species by Ortiz, Javier Esteban et al.
 
Accepted Manuscript
Cholinesterase-inhibitory effect and in silico analysis of alkaloids from
bulbs of Hieronymiella species
Javier E. Ortiz , Adriana Garro , Natalia B. Pigni ,
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Background: In Argentina, the Amaryllidaceae family (59 species) comprises a wide variety of 
genera, only a few species have been investigated as a potential source of cholinesterases inhibitors 
to treat Alzheimer disease (AD). 
Purpose: To study the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory 
activities of the basic dichloromethane extracts (E) from Hieronymiella aurea, H. caletensis, H. 
clidanthoides, H. marginata, and H. speciosa species, as well as the isolated compounds from these 
plant extracts. 
Study design and methods: AChE and BChE inhibitory activities were evaluated with the Ellman's 
spectrophotometric method. The alkaloids composition from the E was obtained by gas 
chromatography-mass spectrometry (GC-MS). The E were successively chromatographed on a silica 
gel column and permeated on Sephadex LH-20 column to afford the main alkaloids identified by 
means of spectroscopic data. Additionally, an in silico study was carried out.  
Results: Nine known alkaloids were isolated from the E of five Hieronymiella species. Galanthamine 
was identified in all the species by GC-MS standing out H. caletensis with a relative abundance of 
9.79% of the total ion current. Strong AChE (IC50 = 1.84 - 15.40 µg/ml) and moderate BChE (IC50 = 
23.74 - 136.40 µg/ml) inhibitory activities were displayed by the extracts. Among the isolated 
alkaloids, only sanguinine and chlidanthine (galanthamine-type alkaloids) demonstrated inhibitory 
activity toward both enzymes. The QTAIM study suggests that sanguinine has the strongest affinity 
towards AChE, attributed to an additional interaction with Ser200 as well as stronger molecular 
interactions Glu199 and His440.These results allowed us to differentiate the molecular behavior in 
the active site among alkaloids possessing different in vitro inhibitory activities.  
Conclusion: Hieronymiella species growing in Argentina represent a rich and widespread source of 
galanthamine and others AChE and BChE inhibitors alkaloids. Additionally, the new trend towards 
the use of natural extracts as pharmaceuticals rather than pure drugs opens a pathway for the 
development of a phytomedicine derived from extracts of Hieronymiella spp. 
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The genus Hieronymiella, which belongs to the Amaryllidaceae family, is native to Argentina and 
comprises five species H. aurea, H. caletensis, H. clidanthoides, H. marginata, and H. speciosa 
(Arroyo-Leuenberger and Dutilh, 2008). To the best of our knowledge, no previous reports about 
phytochemical studies and bioactive properties have been performed in these species.  
The Amaryllidaceae family is an important source of alkaloids with a wide range of biological 
activities including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory effects 
(Bastida et al., 2011; Kulhánková et al., 2013; Cavallaro et al., 2014; Ortiz et al., 2016). 
Galanthamine (Gal) is a long-acting, selective, reversible, and competitive AChE inhibitor 
exclusively produced by Amaryllidaceae family and currently used for the treatment of Alzheimer’s 
disease (AD) (Bastida et al., 2011). Likewise, Gal has shown inhibitory activity against BChE, a 
legitimate therapeutic target for ameliorating the cholinergic deficit considered to be responsible, for 
the declines in cognitive, behavioral, and global functioning characteristics of AD (Greig et al., 2002; 
Anand and Singh, 2013; Zhao et al. 2013).   
In an effort to search for new sources of cholinesterases inhibitors, the phytochemical study of 
Hieronymiella species was conducted. Thus, the enriched alkaloid extracts from the bulbs as well as 
the isolated alkaloids were evaluated for in vitro cholinesterase-inhibitory activities. For further 
insight into the experimental results, a molecular modeling study was carried out. 
Materials and methods 
General experimental procedures 
NMR spectra were performed on Mercury 400 MHz (Palo Alto, CA, USA) and a Varian 500 MHz 
(Palo Alto, CA, USA) instrument using CDCl3 and CD3OD as solvents. All 2D NMR experiments 
were performed using standard pulse sequences. GC-MS analysis of alkaloid extracts were 
performed on a Agilent 6890N GC 5975 instrument (Agilent Technologies, Santa Clara, CA, USA) 
operating in EI mode at 70 eV. A DB-5 MS column (30 m x 0.25 mm x 0.25 μm) was used. The 
temperature program was: 100-180 °C at 15 °C min
−1
, 1 min hold at 180 °C, 180-300 °C at 5 °C 
min
−1
, and 1 min hold at 300 °C. The injector temperature was 280 °C. The flow rate of carrier gas 
(He) was 0.8 ml min
−1
. The split ratio was 1:20. The results obtained were analyzed using AMDIS 
2.64 software. Compounds were identified through the comparison of their mass spectral patterns 
and retention index (RI) with those of previously isolated alkaloids. RIs were calculated through 














total ion current (TIC) in each chromatogram, which was used for comparison of relative abundance 
between components of the extract. HRESIMS data were obtained via LC/MSD-TOF (Agilent 2006) 
(Agilent Technologies) by direct injection of the compounds dissolved in MeOH. All solvents used 
were of analytical grade. Chloroform was purchased from Fisher (USA); methanol (MeOH) from 
J.T. Baker (USA). Ultra pure water (< 5 µg/L) was obtained from a purification system Arium 
61316-RO plus Arium 611 UV (Sartorius, Germany). Sephadex LH-20 column (column length 20 
cm, diameter 2.5 cm) was equilibrated and then permeated with PE:MeOH:CHCl3 (2:1:1). Column 
chromatography (CC) was performed using silica gel 60A (6−35 μm). For analytical and preparative 
TLC, Merck Sílicagel 60 F254 was carried out. The bands were detected by UV light, iodine vapors 
resublimed, and staining with Dragendorff’s reagent. 
Plant material 
Bulbs from eight samples belonging to five species: Hieronymiella aurea Ravenna, H. caletensis 
Ravenna, H. clidanthoides Pax (two samples), H. marginata (Pax) Hunz (three samples), and H. 
speciosa (R.E. Fr.) Hunz were collected in different sites, in the provinces of Tucumán, Salta, Jujuy, 
and La Rioja (Argentina) during the flowering period between December 2012 and March 2013. The 
species were authenticated by MCS German Roitman (Facultad de Agronomía, Universidad de 
Buenos Aires, Argentina) and then deposited in the herbarium of Universidad de Buenos Aires under 
an specific herbarium code as follows: IBT-Arg 7 (H. aurea, from Los Cardones, Salta); IBT-Arg 8 
(H. caletensis, from Tilcara, Jujuy); IBT-Arg 9 (H. clidanthoides, from Los Quilmes, Tucumán); IBT-
Arg 10 (H. clidanthoides, from Chepes, La Rioja); IBT-Arg 11 (H. marginata, from Tafì del Valle, 
Tucumán); IBT-Arg 12 (H. marginata, from El Volcán, Jujuy); IBT-Arg 13 (H. marginata, from 
Tumbaya, Jujuy); and IBT-Arg 14 (H. speciosa, from San Antonio de los Cobres, Salta). 
Extraction and isolation 
Dry powdered bulb material (100-300 g, depending on the species) was macerated in H2SO4 2% for 4 
h in ultrasonic bath (3 × 1000 ml). Subsequently, samples were centrifuged at 5000 rpm (10 min), 
and the supernatant was transferred to another flask where it was defatted with of diethylether (3 × 
500 ml). The aqueous solution was led to pH 11-12 with 10% NaOH and the alkaloids were 
extracted with dichloromethane (3 × 500 ml). The organic phase was dried with anhydrous sodium 
sulfate and then evaporated to obtain the basic dichloromethane extracts named as HE1 (H. aurea), 
HE2 (H. caletensis), HE3 (H. clidanthoides, Los Quilmes), HE4 (H. clidanthoides, Chepes), HE5 (H. 
marginata, Tafí del Valle), HE6 (H. marginata, El Volcán), HE7 (H. marginata, Tumbaya), and 














H. aurea extract (HE1) 
The HE1 (380 mg, yield extract w/w: 0.32%) was dissolved in MeOH (3 ml) and permeated with 
MeOH in a Sephadex LH-20 column (51 cm length, 5 cm i.d.) to give twenty fractions. After TLC 
(Cl3CH/MeOH/NH3, 90:9:1) comparison, fractions with similar retention factor were combined to 
give five subfractions (I−V): I (1): 26.8 mg, II (2-5): 170 mg, III (6-9): 60.3 mg, IV (10-12): 43.9 
mg, and V (13-20): 72 mg. Fraction II was consecutively chromatographed on a silica gel column 
(CC) using gradient elution from n-hexane/EtOAc (2:8−0:10) to EtOAc/MeOH (9:1) to afford 15 mg 
of haemanthamine (11) and 8 mg of crinamine (12), while fraction IV gave 5 mg of lycorine (18) by 
precipitation. 
H. caletensis extract (HE2) 
Column on Sephadex LH-20 (permeated with MeOH, 51 cm length, 5 cm i.d.) of HE2 (310 mg, 
yield extract w/w: 0.28%) dissolved in MeOH (2.5 ml) gave twelve fractions. After TLC comparison 
fractions with similar TLC patterns were combined in four subfractions (I−IV): I (1-3): 66 mg, II (4-
5): 73.4 mg, III (6-8): 82.5 mg, and IV (9-12): 83.9 mg. Consecutively, fraction III was permeated 
with MeOH through Sephadex LH-20 column (30 cm length, 2.5 cm i.d.) giving ten subfractions, 
whereas subfractions 4-6 were combined and subjected to preparative TLC (Cl3CH/MeOH/NH3, 
90:9:1), to afford 5 mg of Gal (2). Fraction IV gave 20 mg of lycorine (18) by direct precipitation.  
H. clidanthoides extract (HE3) (sample from Los Quilmes, Tucumán) 
The HE3 (410 mg, yield extract w/w: 0.31%) was roughly separated by SiO2 flash CC (10 cm length, 
5 cm i.d.) using an n-hexane/EtOAc/CH2Cl2/MeOH gradient to give five fractions: I (n-
hexano/EtOAc, 1:4) 80 mg, II (EtOAc) 120 mg, III (EtOAc/CH2Cl2, 1:1) 78 mg, IV (EtOAc/MeOH, 
9.5:0.5) 50 mg, and V (EtOAc/MeOH, 9:1) 60 mg. Fraction II was applied onto a Sephadex LH-20 
column (length 40 cm, 4 cm i.d., MeOH) to give twelve fractions. After TLC comparison, fractions 
with similar retention factor were combined to give three subfractions (IIa− IIc). Fraction IIb (80 
mg) was subjected to preparative TLC (Cl3CH/MeOH/NH3, 90:9:1) to afford hamayne (15) (10 mg) 
and 11-hydroxyvittatine (16) (4 mg). 
H. marginata extract (HE5) (sample from Tafì del Valle, Tucumán) 
The HE5 (520 mg, yield extract w/w: 0.32%) was dissolved and then permeated with MeOH through 
a Sephadex LH-20 column (51 cm length, 5 cm i.d.) affording fifteen fractions. After TLC 














95 mg, II (4-6): 150 mg, III: (7-8) 200 mg, and IV (9-10): 55 mg. Fraction II and fraction III were 
dissolved and then permeated with PE/MeOH/Cl3CH (50:25:25) onto a Sephadex LH-20 column 
(length 35.5 cm, 2.5 cm i.d.). Fraction II yielded 15 mg of tazettine (13), while fraction III gave 
eight fractions. Fractions 5-7 were pooled and subjected to preparative TLC (silica gel with n-
hexane/EtOAc/CHCl3/MeOH, 35:40:20:5, in NH3 atmosphere) to afford 4 mg of sanguinine (4).  
H. marginata extract (HE6) (sample from El Volcán, Jujuy) 
The HE6 (360 mg, yield extract w/w: 0.14%) afforded 97 mg of lycorine by direct precipitation. 
Then, the extract was subjected to CC eluted with a EtOAc/MeOH gradient to afford 120 fractions, 
which were combined to give four groups of subfractions (I−IV): I (5–20, EtOAc/MeOH, 3:1) 30 
mg,  II (21–45, EtOAc/MeOH 1:1) 34 mg, III (46–102, EtOAc/MeOH 1:3) 125 mg, and IV (103–
120, MeOH) 59 mg. Fraction III was permeated through a Sephadex LH-20 column (30 cm length, 
2.5 cm i.d.) giving twelve fractions, whereas 5-8 were combined and then subjected to preparative 
TLC to afford 6 mg of chlidanthine (3). Fraction IV yielded 20 mg of lycorine (18) by direct 
precipitation.  





NMR) with those of authentic samples obtained from other plant sources and the reported data 
(Likhitwitayawuid et al., 1993; Viladomat et al., 1994; Bastida et al. 1995, 2006, 2011). The 
chemical structures of the isolated alkaloids are shown in Fig. 1, while the chromatograms indicating 
the peaks corresponding to the isolated alkaloids are shown into supplementary material (Fig. 1S). 
Insert Fig. 1 
Acetylcholinesterase and butyrylcholinesterase inhibitory bioassay 
Cholinesterase inhibitory activities were evaluated according to Ellman et al. (1961) with some 
modifications (Ortiz et al., 2016). The AChE and BChE activity assay was carried out using 
acetylthiocholine iodide and butyrylthiocholine iodide as substrates, respectively. Briefly, 50 μL of 
AChE or BChE in buffer phosphate (8 mM K2HPO4, 2.3 mM NaH2PO4, 0.15 M NaCl, pH 7.6) and 
50 μL of the sample dissolved in the same buffer, were added to the wells of a microplate. The plates 
were incubated for 30 min at room temperature before the addition of 100 μL of the substrate 
solution (0.1 M Na2HPO4, 0.5 M DTNB, 0.6 mM ATCI in Millipore water, pH 7.5). The absorbance 
was read in a Thermo scientific multiskan FC microplate photometer at 405 nm after 5 min. Enzyme 














inhibitor. The results obtained were analyzed with the software package Prism (Graph Pad Inc., San 
Diego, CA, USA). The values were expressed as half-maximal inhibitory concentration IC50 (µg/ml 
for extracts and µM for compounds), and were calculated as means ± SD of 3 individual 
determinations. The enzymes AChE from the electric eel Electrophorus electricus and BChE from 
equine serum (Sigma-Aldrich) were used. Galanthamine (Sigma-Aldrich) was used as a positive 
control. 
Molecular modeling 
Automated docking setup. 
An X-ray structure available in the Protein Data Bank (http://www.rcsb.org) was used as follows: 
TcAChE (1DX6) (Greenblatt et al., 1999) and eqBChE (UniProtAC Q9N1N9). Molecular docking 
was conducted using AutoDock 4 (Trott and Olson, 2010). This program was adopted to perform 
molecular docking; the receptor structure was defined as rigid, and the grid dimensions were 50, 40, 
and 60 for the X, Y, and Z axes, respectively, in the catalytic site region with a resolution of 0.375 Å. 
Gasteiger charges were assigned for all the compounds, and nonpolar hydrogen atoms were merged. 
All torsions of the ligand were allowed to rotate during docking. The value for the exhaustiveness of 
the search was 400, whereas the number of poses collected was 200. All graphic manipulations and 
visualizations were performed using the AutoDock Tools 1.5.4 (Sanner, 1999) and ligand docking 
with Autodock Vina 1.1.1. 
Molecular dynamic simulations (MDS) 
The complex geometries from docking were soaked in boxes of explicit water using the TIP3P 
model (Jorgensen et al., 1983) and subjected to MDS. All MDS were performed with the Amber 
software package using periodic boundary conditions and cubic simulation cells. The particle mesh 
Ewald method (Darden et al., 1993) was applied using a grid spacing of 1.2 Å, a spline interpolation 
order of 4, and a real space direct sum cutoff of 10 Å. The SHAKE algorithm was applied allowing 
for an integration time step of 2 fs. MDS were carried out at a 300 K target temperature and extended 
to 20 ns overall simulation time. The isothermal−isobaric (NPT) ensemble was employed using 
Berendsen coupling to a baro/thermostat (target pressure 1 atm, relaxation time 0.1 ps). Post MD 















MM-GBSA free energy decomposition 
To determine the residues of the AChE and BChE catalytic site involved in the interactions, 
histograms of the interaction energy were used. The MM-GBSA free energy decomposition using the 
mm_pbsa program in AMBER12 was employed to corroborate the amino acids interacting with the 
ligands.  
QTAIM analysis 
After the QM/MM calculation, the optimized geometries were used as input for QTAIM analysis 
(Bader, 1985), which was performed with the help of Multiwfn software (Lu and Chen, 2012) using 
the wave functions generated at the B3LYP-D/6-31G (d) level. This type of calculation has been 
used in recent studies because it ensures a reasonable compromise between the wave function quality 
required to obtain reliable values of ρ(r) and the available computer power, considering the extension 
of the system in the study (Andujar et al., 2012; Gutierrez et al., 2016; Tosso et al., 2013; Vega-Hissi 
et al., 2015). 
Results and discussion 
GC-MS analysis of Hieronymiella extracts  
Twenty six compounds suggesting alkaloid structures were detected by comparing their mass 
fragmentation patterns with standard reference spectra in home-made databases, nineteen of them 
were identified from their MS data and retention indexes and are listed in Table 1, whereas seven 
were not recognized among the Amaryllidaceae alkaloids. 
Gal was identified in all Hieronymiella species in a range of 0.1 − 9.79% (TIC). H. caletensis 
showed the highest relative abundance of Gal followed by H. marginata (from Tumbaya) and H. 
speciosa with 4.04 and 3.45%, respectively. Curiously, in H. clidanthoides from Tucumán province 
and H. marginata from Volcán district (Jujuy province) species, Gal was not detected. These results 
are in agreement with previous reports on Amaryllidaceae species showing variability on alkaloid 
profiles according to the collection site, as Galanthus elwesii and G. nivalis populations from 
Bulgaria (Berkov et al., 2011), Leucojum aestivum (subsp. pulchellum) from Bulgaria and the 
Balearic Islands (Berkov et al., 2013), as well as H. jamesoni from Argentina (Ortiz et al., 2012; 
Cavallaro et al., 2014). On the other hand, lycorine was detected in all extracts samples, even those 














occurring Amaryllidaceae alkaloid (Bastida et al., 2011). H. marginata from Volcán (Jujuy province) 
showed the highest abundance of lycorine with 92.98% of TIC. Lycorine possesses a wide range of 
bioactivities, standing out its ability as inhibitor towards ascorbic acid biosynthesis, organogenesis, 
growth, and cell division (Bastida et al., 2011). 
The bulb extract from H. aurea (HE1) showed the highest number of detected alkaloids (sixteen 
alkaloids, 95.46% of TIC). From them, ten alkaloids were identified by their mass fragmentation 
pattern and RIs. Gal (2) was also detected (2.82% TIC). Haemanthamine/crinamine (11/12) and 
crinan-3-one (20) were found in notably high abundance: 42.04% and 19.87% of TIC, respectively. 
Hemanthamine (11) and crinamine (12) displayed pronounced cell growth inhibitory activities 
against a variety of tumor cells, whereas hemanthamine also shown strong antiretroviral activity 
(Bastida et al., 2006). 
Insert Table 1 
Regarding H. caletensis (HE2), Gal (2), tazettinol (17), and lycorine (18) were identified. It is 
remarkable the relatively high amount of tazettinol (17) and Gal (2), with 49.09 and 9.79% of TIC, 
respectively. This species together with Zephyranthes filifolia (Ortiz et al., 2012) represent an 
important source of Gal (2) among Amaryllidaceae from Argentina (supplementary material, Fig. 
1S).  
Concerning to H. clidanthoides (HE3) from Tucumán province, nine alkaloids were detected. 
Hamayne (15)/11-hydroxyvittatine (16), lycorine (18) and ungiminorine (21) were the most 
abundant. The alkaloid (21) was reported as AChE inhibitor (Ingkaninan y col., 2000). Furthermore, 
two unknown compounds m/z 289 (8) and m/z 344(10) were detected. Another sample of this species 
obtained from La Rioja (HE4) differed notably in its chemical composition (Table 1). 
The GC-MS analysis of the three different H. marginata samples from Tucumán and Jujuy provinces 
showed diverse alkaloid profiles, even between those from near places. Among the known alkaloids 
detected in HE5, sanguinine (4) which accounted for 2.63% of TIC, is a galanthamine-type 
compound with an hydroxyl group at C-9 instead of a methoxyl group that showed an AChE 
inhibitory activity around 10 times higher than Gal (Lopez et al., 2002). HE5 and HE6 showed a 
similar alkaloid profile and were characterized by lycorine (18) and tazettinol (17) as the main 
alkaloids, together with Gal (2), trisphaeridine (1) and anhydrolycorine (7). Regarding extract HE7, 
just three alkaloids were identified: chlidanthine (3), lycorine (18), and anhydrolycorine (7), which 














Regarding the H. speciosa extract (HE8) the low-occurring alkaloid lycoramine (5), was detected in 
a high abundance (25-30% of TIC). There are discrepancies among different authors regarding its 
AChE inhibition (Irwin and Smith, 1960; Lopez et al., 2002; Kulhánková et al., 2013). 
AChE and BChE inhibitory activity  
The bulb extracts of H. aurea, H. caletensis, H. clidanthoides, H. marginata, and H. speciosa species 
were evaluated in vitro as inhibitors of AChE and BChE. The results are summarized in Table 2. All 
the Hieronymiella extracts showed strong AChE inhibitory effect (IC50 values ≤ to 15.40 µg/ml), 
HE5 being the most potent (IC50 = 1.84 µg/ml). Furthermore, all these extracts exhibited moderate 
BChE inhibitory activity (IC50 = 23.74-136.40 µg/ml), the HE8 and HE5 extracts displaying the 
highest BChE inhibition (IC50 = 23.74 and 36.07 µg/ml, respectively). Since the cholinesterase 
inhibitory activity of Hieronymiella species could be explained by the presence of Gal (2), others 
inhibitor alkaloids as sanguinine (4), chlidanthine (3), lycoramine (5), and ungiminorine (21) can 
also contribute to the overall extract inhibition, especially in those extracts whose Gal (2) content 
was minor or nonexistent. Thus, the high inhibitory activity of HE5 over AChE could be related to 
the presence of sanguinine (4), the most potent and natural-occurring Amaryllidaceae alkaloid 
(Lopez et al., 2002). Regarding lycoramine (5), a galanthamine-type alkaloid, there is a disagreement 
among different authors about its AChE inhibitory effect (Irwin and Smith, 1960; Lopez et al., 2002; 
Kulhánková et al., 2013). 
Insert Table 2 
Considering that both HE6 and HE8 differ notably in the abundance of lycoramine (5), (0.85 and 
29.84% of TIC, respectively), possess similar abundance of Gal (4.04 and 3.45% of TIC), and have 
similar IC50 values (5.50 ± 0.01 and 5.88 ± 0.03 µg/ml), these results suggest that lycoramine (5) has 
weak or null inhibitory activity against AChE and support the results of Lopez et al., 2002. On the 
other hand, these species showed different BChE inhibitory effects, being that of HE8 higher than 
HE6, suggesting lycoramine (5), as a promising BChE inhibitor. Finally, since some alkaloids were 
not identified in the extracts, they could play a key role on the cholinesterase inhibition of the studied 
extracts.  
The nine isolated alkaloids from Hieronimyella species were assayed as inhibitors of AChE and 
BChE. Although many authors have previously considered that AChE inhibitory effect lesser than 
500 µM can be considered as active (Wink, 2000; Elgorashi et al., 2004), herein those alkaloids with 














inhibition, is in accordance with previous publications (Kulhánková et al., 2013; Cahlíková et al., 
2013; Cavallaro et al., 2014) and represent another evidence of the Amaryllidaceae alkaloids 
selectivity toward AChE. In this regard, Gal (2), sanguinine (4) and chlidanthine (3) showed AChE 
inhibitory effect (IC50 values =1.0, 0.1, and 23.50 µM, respectively), and weak BChE inhibitory 
activity (IC50 values = 14, 21.50, and 196.79 µM, respectively). The other tested alkaloids did not 
show inhibitory activity against either enzyme (IC50 > 200 μM).  
Molecular modeling 
To better understand the experimental results, a molecular modeling study on both TcAChE and 
eqBChE, using combined techniques (Docking calculations, MD simulations, and QTAIM 
computations) was performed.  
Although these studies were conducted with TcAChE instead of EeAChE, several reports have 
shown that AChE from different species share 65% amino acid sequence homology and similar 
overall structures (Lee et al., 2007; Khan et al., 2009; Cheung et al., 2012; Brus et al., 2014; 
Atanasova et al., 2015; Cortes et al., 2015). 
Insert Fig. 2 
The docking study predicts that all these alkaloids bind in the same region of the active site of AChE; 
however, MD simulations indicate that these molecules are arranged spatially in several ways and 
are interacting with different amino acids. Such results might be well appreciated in the analysis per 
residue which has been performed for different compounds (Fig. 2). While the most active 
compounds sanguinine (Fig. 2a), Gal (Fig. 2b), and chlidanthine interact mainly with Trp84, Gly118, 
Glu199, Ser200, Phe330, and His440; lycorine (Fig. 2c) produces their main interactions with Tyr70, 
Asp72, Val71, Trp84, Tyr121, and Ser122. Similar results to those of lycorine were obtained for the 
rest of inactive isolated alkaloids. It is interesting to note that the alkaloid-amino-acids interactions 
involved in the active site of AChE are markedly different comparing the galanthamine-type 
alkaloids to the rest of the simulated alkaloids. These results are in complete agreement with the 
experimental data and allow us to differentiate between the strong inhibitors from the inactive ones. 
However, in order to go further and try to explain the higher inhibitory activity observed for 
sanguinine respect to Gal and chlidanthine, it is necessary to obtain more accurate and detailed 
information about the molecular interactions which stabilize and destabilize the ligand-receptor 
complexes. Thus, QTAIM calculations on the complexes of Gal, sanguinine, and chlidanthine with 














alkaloids at the binding pocket of AChE. In such figure it is possible to observe that Gal displays six 
strong stabilizing interactions with the following amino acids: Trp84, Gly118, Glu 199, Ser200, 
Phe330, and His490 (Fig. 3a). According to the QTAIM analysis, ρ(rb) values for these interactions 
are 0.0241, 0.0521, 0.0615, 0.0136, 0.0098, and 0.0065au, respectively. These six interactions are 
also present in the complex of sanguinine with AChE (Fig. 3b).  
Insert Fig. 3 
However, for sanguinine the ρ(rb) values obtained for the same interactions are: 0.025, 0.0352, 
0.0685, 0.0345, 0.0088, and 0.017au, respectively. It should be noted that the molecular interactions 
obtained for sanguinine are stronger than those observed for Gal (supplementary material, Fig. 2S). 
The exception is the interaction with Gly118 in which the values are higher for Gal. The only 
structural difference between sanguinine and Gal is the replacement of OCH3 group by OH. 
However, such difference allows sanguinine to establish a strong interaction with Ser200. This 
interaction is missing in Gal due to the exclusive character as proton acceptor of the OCH3 group. 
On the basis of our QTAIM study it is reasonable to think that the stronger affinity observed for 
sanguinine might be attributed to this additional interaction with Ser200 as well as to the stronger 
molecular interactions observed for sanguinine in comparison to those of Gal for the Glu199 and 
His440. The differential interactions displayed by the complexes of sanguinine and Gal might be 
well appreciated in Fig. 3 and supplementary material (Fig. 2S). 
It has been reported that the extra hydroxyl group of sanguinine (4) available for potential interaction 
with AChE could explain the strong inhibitory activity of this alkaloid (Lopez et al., 2002). Our 
results support such hypothesis. The alkaloid chlidanthine (3) is a positional isomer of Gal, however 
it has a very weak inhibitory effect against AChE in comparison to Gal and sanguinine. Our results 
can explain very well such behavior. While chlidanthine is located practically in the same place of 
the active site of AChE, their spatial arrangement is very different from those of Gal and sanguinine. 
This can be clearly seen in Fig. 3c. It is interesting to note that this different spatial ordering is 
responsible for the weaker interactions of chlidanthine respect to those of sanguinine and Gal (see 
supplementary material, Fig. 2S). These results are in a complete agreement with the experimental 
data and allow us to understand the markedly weak inhibitory effect of chlidanthine in comparison to 
those of sanguinine and Gal. 
Likewise, the results obtained for BChE are also in agreement with the experimental data and explain 














alkaloids bind in the same region of the active site of BChE and the MD simulations indicate that 
these molecules are arranged spatially in several ways and are interacting with different amino acids. 
The Fig. 3Sa shows the analysis per residue performed for sanguinine. From this figure it is possible 
to determine the main stabilizing interactions for the complex sanguinine-BChE; they are with 
Trp85, Gly118, Glu199, Ser200, Tyr334 and His440. It should be noted that these results are very 
similar to those recently reported for the interactions of Gal with BChE (Ortiz et al., 2016), 
indicating that both sanguinine and Gal are good ligands for BChE. In contrast, the results obtained 
for chlidanthine and lycorine indicate that the stabilizing interactions for the complexes of these 
alkaloids with BChE are significantly weaker than those observed for sanguinine and Gal 
(supplementary material, Fig. 3Sb). Similar results were obtained for the rest of inactive alkaloids 
reported here. 
Conclusions 
Argentinean Hieronymiella species represent a rich and widespread source of alkaloids, as well as 
potent AChE and BChE inhibitors. Such activity might be explained at least in part by the content of 
Gal and sanguinine as well as by other unknown alkaloids. The demand for renewable sources of Gal 
and other new cholinesterases inhibitors, and the new trend towards the use of natural extracts as 
medicines instead of pure drugs, could open an avenue for the development of possible Alzheimer 
disease´s treatment by using Hieronymiella species. 
Furthermore, the results obtained from molecular modeling study, have allowed us to understand at a 
molecular level the differential behavior of the main alkaloids found in Amaryllidaceae species 
reported here. Thus, it is possible to explain the higher affinity of Gal and sanguinine over other 
alkaloids like chlidanthine, lycorine, haemanthamine, and tazettine among others. Besides, the 
QTAIM studies have also allowed to appreciate more subtle differences in the interactions of each 
alkaloid among the most active ones; such information can be certainly very useful for the design 
and search for new inhibitors of cholinesterases, obtained whether from natural sources or by 
synthesis. 
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Table 1. GC-MS data for Hieronymiella species alkaloid extracts. Values are expressed as a relative 
percentage of TIC. 
Compound RI HE1 HE2 HE3 HE4 HE5 HE6 HE7  HE8 M
+
 MS 
trisphaeridine (1) 2275.0 0.1  0.21  0.12 0.11  0.14 223(100) 
222(36), 138(26), 224(20), 111(17), 
164(17), 137(12), 165(10),167(10), 166(9) 
galanthamine (2) 2413.9 2.82 9.79  0.16 0.10 4.04  3.45 287(83) 
286(100), 270(13), 244(24), 230(12), 
216(33), 174(27), 115(12) 
chlidanthine (3) 2421.6       3.18  287(100) 
256(71), 202(62), 286(52), 255(35), 
115(35), 165(34), 96(32), 212(31), 
160(31) 
sanguinine (4) 2428.2     2.63    273(100) 
272(86), 160(49), 202(47), 115(22), 
256(21), 274(19), 212(17), 152(16), 
165(15) 
lycoramine (5) 2431.4      0.85  29.84 289 (57) 
288(100), 289(58), 115(13), 202(12), 
187(11), 44(10), 290(9), 188(9), 189(9), 
232(8) 
narwedine (6) 2492.4 0.10 1.66    0.65  0.20 285(84) 
284(100), 242(18), 216(20), 199(18), 
174(31), 128(16), 115(16) 
anhydrolycorine (7) 2510.4 0.46 0.10 0.19 0.53 0.10 0.10 0.10 1.39 251(43) 
250(100), 192(13), 191(11), 165(4), 
164(3), 139(2), 124(7) 
m/z 289 (8) 2560.9 0.59  3.36     1.11 289(100) 
218(44), 217(35), 260(25), 202 (22), 




2578.3   4.40      275(100) 
204(77), 203(48), 188(36), 187(33), 
258(23), 202(23), 246(22), 276(18), 
274(18) 
m/z 344 (10) 2607.8   14.7      344(100) 
345(39), 346(10), 226(58), 75(42), 59(39), 
101(37), 161(35), 212(33), 227(31) 
haemanthamine/ 
crinaminea (11/12) 
2646.6 42.04   2.34     301(14) 
272(100), 257(10), 240(16), 181(21), 
214(12), 211(14), 128(8) 
tazettine (13) 2657.1 0.39   32.27 62.40   25.46 331(23) 
298(18), 247(100), 201(18), 181(16), 
70(31) 
hippamine (14) 2676.6  2.03 2.7 0.20     301(15) 
226(100), 227(79), 250(16), 252(13), 




2712.7 8.22  44.88     0.20 258(100) 
181(17), 259(15), 186 (15), 128 (14), 
115(13), 211 (13), 242 (10), 214(10), 
212(8) 
tazettinol (17) 2717.1  49.09   13.64 19.10   317(24) 
247(100), 70(33), 71(26), 115(21), 
173(20), 201(17), 248(13), 44(13), 
230(12) 
lycorine (18) 2753.9 3.83 25.77 24.23 57.46 16.32 73.12 92.98 28.21 287(31) 
226(100), 227(79), 268(24), 286(19), 
250(15), 147(15), 211(7) 
m/z 373 (19) 2778.5 1.90        373(100) 
374(21), 312(93), 298(63), 212(50), 
314(43), 372(41), 375(39), 340(35), 
326(32) 
crinan-3-one (20) 2843.2 19.87        271(100) 
181(54), 270(37), 211(19), 272(17), 
153(12), 152(11), 240(10), 238(9), 182(8) 
ungiminorine (21) 2883.0   5.19      316(19) 
268(100), 212(72), 299(60), 214(57), 
242(51), 250(34), 224(24), 225(20), 
147(19) 
m/z 257 (22) 2899.6 0.67    4.00    257(100) 
256(48), 181(26), 258(16), 115(9), 211(8) 
153(7), 188(7), 152(7), 128(57) 
m/z 271 (23) 2930.9 2.52        271(100) 
181(47), 270(33), 211(17), 272(17), 




2973.5 8.71        125(100) 
96(20), 126(80), 124(55), 94(23), 42(19), 
81(16), 82(16), 97(16), 95(15) 
m/z 311 (25) 2994.9 0.46        311 (100) 
312(186), 310(129), 281(103), 296(76), 















m/z 297 (26) 3297.9 2.78        297(100) 
296(43), 298(16), 149(11), 253(10), 
252(10), 282(8), 299(6), 77(6), 251(6) 
Total alkaloids 95.46 88.44 99.86 92.96 99.31 97.97 96.26 90.00   
aCan not be distinguished by GC-MS. RI: Retention Index. HE1: Hieronymiella aurea Extract (Los Cardones , Salta);  HE2: H. caletensis  
Extract (Tilcara, Jujuy); HE3: H. clidanthoides (Los Quilmes, Tucumán); HE4: H. clidanthoides Extract (Chepes, La Rioja); HE5: H. 
marginata Extract (Tafí del Valle, Tucumán); HE6: H. marginata Extract (El Volcán, Jujuy); HE7: H. marginata Extract (Tumbaya, Jujuy);); 






AChE and BChE inhibitory activities of extracts and alkaloids isolated from 




 of Hieronymiella spp extracts
 
AChE BChE 
HE1 5.84 ± 0.01 >200 
HE2 4.80 ± 0.02 106.48 ± 0.05 
HE3 15.40 ± 0.02 101.27 ± 0.02 
HE4 11.63 ± 0.02 121.86 ± 0.04 
HE5 1.84 ± 0.01 36.07 ± 0.02 
HE6 5.50 ±  0.01 115.00 ± 0.08 
HE7 7.80 ± 0.01 136.40 ± 0.07 
HE8 5.88 ± 0.03 23.74 ± 0.02 
Isolated Alkaloids  IC50 [μM]
 a
 
haemanthamine (11) >200 >200 
crinamine (12) >200 > 200 
lycorine (18) >200 >200 
11-OH-vittatine (16) >200 > 200 
hamayne (15) >200 > 200 
tazettine (13) >200 >200 
sanguinine (4) 0.10 ± 0.03 21.50 ± 0.04 
chlidanthine (3) 23,50 ± 0,65 196,79 ± 2,67 
galanthamine (2)
 b
 1 ± 0.05 14 ± 0.03 
a 
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Figure 2. Histograms showing the interaction energies of A) Sanguinine, B) Gal, and C) Lycorine 






















Figure 3. Molecular graph showing the non-covalent interactions of Gal (a), sanguinine (b), and 
chlidanthine (c) with the main residues at the binding pocket of AChE. The elements of the topology 
of the electron density are shown: pink spheres represent the bond paths connecting the nuclei and 
the critical bond points are represented as red spheres. (For interpretation of the references to colour 
in this figure legend, the reader is referred to the web version of this article). 
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